CatalystFDA/Bio

Regeneron Secures FDA Approval for Rare Genetic Disorder Drug

FDA approval for a rare disorder drug is a major regulatory catalyst.

What changed

FDA approval for a rare disorder drug is a major regulatory catalyst.

Why it matters

FDA approval for a rare disorder drug is a major regulatory catalyst. — impact context not separately stored; see What changed.

Sources